Arkolith/Insider Trading/EDSA/Form 4

Nijhawan Pardeep

Chief Executive Officer, Director, 10% OwnerEdesa Biotech, Inc. (EDSA) · full profile →Form 4 · filed Mar 2, 2026
Net Buying
Open-Market Buys
$99K
Open-Market Sells
$0
Net Open-Market Flow
$99K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Grant(A)10K—$0626K
Feb 27, 2026Buy(P)30K$2.22$67K372K
Feb 26, 2026Buy(P)21K$1.58$33K616K

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-26-001267) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML